Graeme J. Carroll
Perth, WA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
EULAR 2025 classification criteria for haemochromatosis arthropathy.
Journal: Annals of the rheumatic diseases
Published: May 19, 2025
Agreement Between Self-Reported Antirheumatic Medications and Pharmaceutical Claims in an Australian Inflammatory Arthritis Cohort.
Journal: ACR open rheumatology
Published: March 24, 2025
Undetectable mannose binding lectin confers increased risk for serious infection in rheumatoid arthritis.
Journal: European journal of rheumatology
Published: February 14, 2022
VEXAS syndrome: favourable clinical and partial haematological responses to subcutaneous abatacept therapy with 30-month follow-up.
Journal: Rheumatology (Oxford, England)
Published: October 27, 2021
Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia.
Journal: Rheumatology (Oxford, England)
Published: August 24, 2021
Long-term Clinical Outcomes in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.
Journal: Mayo Clinic proceedings. Innovations, quality & outcomes
Published: July 01, 2021
Oral Complementary Medicine Use among People with Inflammatory Arthritis: An Australian Rheumatology Association Database Analysis.
Journal: International journal of rheumatology
Published: February 18, 2020
Undetectable Mannose Binding Lectin and Corticosteroids Increase Serious Infection Risk in Rheumatoid Arthritis.
Journal: The journal of allergy and clinical immunology. In practice
Published: March 22, 2016
Efficacy of patient information concerning casts applied post-fracture.
Journal: ANZ journal of surgery
Published: April 19, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026